Stepping up the game: scale up and international expansion for British AI medical software

我是牛津心跳公司(OxHB)的首席执行官，这是一家使命驱动的医疗技术初创公司。我也是皇家工程院的企业研究员，牛津大学的生物医学工程博士，柏林洪堡大学的计算机科学硕士(辅修商业)，之前是巴黎索尼的人工智能研究员。我被《福布斯》评为“致力于改变世界的创始人”，最近还因“富有想象力的开创性工作，带来了支持医学干预的新技术”而获得了BioMedEng创新奖。在获得博士学位并目睹了外科手术现状的缺陷后，我创立了OxHB，将我的学术研究转化为临床实践。我既是该公司的首席执行官，也是该公司的首席技术官，该公司开发了创新的人工智能软件PreSize Neurovailures，允许外科医生模拟在血管内放置支架，以便更安全有效地治疗心血管疾病，定义了手术规划的新标准。我们已经获得CE认证和ISO13485认证，目前正在进行一项英国范围内的临床试验，以收集其在临床实践中影响的证据，资金来自英国政府享有盛誉的AI in Health and Care奖和NIHR。女性创新奖将支持我们为扩大规模和国际化做准备--这是我们发展业务并成为全球参与者的关键下一步。该奖项的非财务支持，即关于扩大规模、销售和谈判技能以及建立新商业模式的专家建议，将有助于我们及时准备在全球范围内扩展我们的业务，从而帮助OxHB进入其旅程的新阶段。该项目的成功将看到我们在该奖项的支持下所做的努力，蓬勃发展到商业活动，更重要的是，造福于许多患者的生活。我们以前项目的结果获得了许多奖项，包括NHS创新奖2017年(HEE)，Wire被评为2018年最佳英国医疗创业公司，我们的PreSize技术最近被《泰晤士报》(2021年9月6日)报道。

I am a CEO of Oxford Heartbeat (OxHB) - mission-driven medical technology startup. I am also an Enterprise Fellow of The Royal Academy of Engineering, a PhD in Biomedical Engineering from University of Oxford, MSc in Computer Science from Humboldt University of Berlin (minor in Business) and was previously Researcher in AI at Sony in Paris. I was named a "founder striving to change the world" by Forbes and recently awarded the BioMedEng Innovation Prize for "imaginative and ground breaking work that led to new technologies supporting medical interventions."After obtaining a PhD and having witnessed the shortcomings of the status quo in surgery, I founded OxHB to translate my academic research to clinical practice. I am both CEO and CTO of the company, which has developed innovative AI software PreSize Neurovascular allowing surgeons to simulate placement of stent implants within blood vessels so they can more safely and effectively treat cardiovascular diseases, defining a new standard of surgical planning.We have achieved CE-marking and ISO13485-certification and are now running a UK-wide clinical trial to collect evidence of its impact in clinical practice, funded by the UK Government's prestigious AI in Health and Care Award and NIHR.The Women In Innovation Award will support our preparations for scale up and internationalisation - the critical next step to grow our business and become global players.The award's non-financial support, i.e., expert advice on scaling up, sales and negotiations skills and building new business models, will contribute to our timely preparation for expansion of our business globally, thus helping OxHB enter a new stage of its journey.Success of this project would be seeing our efforts, supported by this award, flourishing into commercial engagements, and importantly, benefitting many patients' lives.Results from our previous projects received numerous awards, including NHS Innovation Award 2017 (HEE), WIRED "Best UK Healthcare Start-up of 2018", and our PreSize technology has been recently featured in The Times (6 September 2021).